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Progressive Motor Neuronopathy: A Critical Role of the
Tubulin Chaperone TBCE in Axonal Tubulin Routing from
the Golgi Apparatus
Michael K. E. Schaefer,1,2Henning Schmalbruch,3 Emmanuelle Buhler,1,2 Catherine Lopez,1,2Natalia Martin,4
Jean-Louis Gue´net,4 and Georg Haase1,2
1Inserm, Unite´ 29, Equipe Avenir, 13273 Marseille, France, 2Aix Marseille Universite´, Institut de Neurobiologie de la Me´diterrane´e, 13284 Marseille, France,
3Panum Institute, University of Copenhagen, DK-2200 Copenhagen, Denmark, and 4Institut Pasteur, 75015 Paris, France
Axonal degeneration represents one of the earliest pathological features in motor neuron diseases. We here studied the underlying
molecular mechanisms in progressive motor neuronopathy ( pmn) mice mutated in the tubulin-specific chaperone TBCE. We demon-
strate that TBCE is a peripheralmembrane-associatedprotein that accumulates at theGolgi apparatus. Inpmnmice, TBCE is destabilized
and disappears from the Golgi apparatus of motor neurons, and microtubules are lost in distal axons. The axonal microtubule loss
proceeds retrogradely in parallel with the axonal dying back process. These degenerative changes are inhibited in a dose-dependent
manner by transgenic TBCE complementation that restores TBCE expression at theGolgi apparatus. In culturedmotor neurons, the pmn
mutation, interference RNA-mediated TBCE depletion, and brefeldin A-mediated Golgi disruption all compromise axonal tubulin rout-
ing.Weconclude thatmotor axons criticallydependonaxonal tubulin routing fromtheGolgi apparatus, aprocess that involvesTBCEand
possibly other tubulin chaperones.
Key words:motor neuron disease; ALS; axon degeneration; tubulin chaperone; microtubules; Golgi apparatus
Introduction
Human motor neuron diseases such as amyotrophic lateral scle-
rosis (ALS) and spinal muscular atrophy (SMA) are incurable
and fatal disorders characterized by loss of motor neuron cell
bodies, axonal degeneration, and skeletal muscle denervation
(for review, see Boillee et al., 2006; Pasinelli and Brown, 2006). In
several ALS and SMAmousemodels, motor axonal degeneration
occursweeks tomonths before cell body loss and displays numer-
ous features of a retrograde “dying back” process. In transgenic
mutant superoxide dismutase 1 G93A mice, a model of familial
ALS1, denervation of endplates appears at presymptomatic stage,
loss of ventral root axons at disease onset, and loss of spinalmotor
neuron cell bodies only at end stage (Fischer et al., 2004) (see also
Kennel et al., 1996a; Frey et al., 2000; Pun et al., 2006). SMA
model mice deficient in neuronal SMN (survival motor neuron)
display extensive muscle denervation and motor axon loss at a
moment when the number of spinal motor neuron cell bodies is
only modestly reduced (Cifuentes-Diaz et al., 2002). Alsin/ALS2
knock-outmice show retrograde axonal degeneration in the dor-
solateral spinal cord tract but no loss of cell bodies in the motor
cortex (Devon et al., 2006; Yamanaka et al., 2006). It remains
unclear however whether axonal dying back is triggered in the
axon itself or whether it is a consequence of degenerative changes
originating in the cell body (Fischer et al., 2004; Conforti et al.,
2007).
We here studied this question in mice with progressive motor
neuronopathy ( pmn). Homozygous pmn mice suffer from a se-
vere motor neuron disease characterized by axonal dying back
(Schmalbruch et al., 1991) and progressive loss of motor units
(Kennel et al., 1996b). Axonal degeneration and clinical disease
course in pmn mice can be attenuated by neurotrophic factor
gene therapy (Sendtner et al., 1992; Sagot et al., 1995a; Haase et
al., 1997) or expression of the axonoprotective WldS protein
(Ferri et al., 2003) but not by overexpression of the antiapoptotic
protein Bcl-2 (Sagot et al., 1995b). We and others showed that
pmnmice are mutated in TBCE (Bo¨mmel et al., 2002; Martin et
al., 2002), one of five tubulin-specific chaperones (TBCA–TBCE)
involved in tubulin folding and dimerization (Tian et al., 1996,
1997). The pmn mutation, a tryptophan to glycine exchange at
the C terminus of TBCE, causes axonal microtubule loss in vivo
(Martin et al., 2002) and, according to Bo¨mmel et al. (2002), also
impedes motor axon growth in vitro.
We identify TBCE as a tubulin chaperone that accumulates at
the cis-Golgi apparatus and demonstrate its requirement for ax-
onal tubulin routing. In spinal motor neurons of early symptom-
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atic pmn mice, the TBCE protein is destabilized, leading to a
drastic reduction in tubulin levels and microtubule densities in
distal axons. Axonal microtubule loss progresses from distal to
proximal, correlates with axonal degeneration, and is inhibited
by transgenic TBCE protein expression. These data help to ex-
plain the axonal dying back process in pmn mice and provide a
mechanistic link between motor axon maintenance and TBCE
function at the Golgi apparatus.
Materials andMethods
Antibodies and reagents. Antiserum against TBCE (SA53) was generated
by immunizing a rabbit with a mixture of two peptides corresponding to
amino acids 87–102 and 389–402 of mouse TBCE (Eurogentec, Liege,
Belgium). A second anti-TBCE antiserum (GP52) was generated against
the same peptides. In control experiments, antisera were preabsorbed
with antigenic peptides or recombinant green fluorescent protein (GF-
P)–TBCE protein (G.Haase andA. Elmarjou, unpublished observation).
Antibodies and their dilutions in immunocytochemistry were as follows:
TBCE (1:300), -tubulin (1:1000; Sigma, St. Louis, MO), III-tubulin
(TuJ1; 1:2000; Babco, Richmond, CA), GFP (monoclonal antibody,
1:1000; Roche, Indianapolis, IN), myelin basic protein (1:500; Chemi-
con, Temecula, CA), neurofilament medium chain (NN18, 1:2000;
Sigma), S-100 (SH-B1, 1:1000; Sigma), and GM130, p115, Vti1a, and
Vti1b (1:250; Becton Dickinson, Walton, KY). Fluorochrome- or horse
radish peroxidase-conjugated secondary antibodies were from Invitro-
gen (Carlsbad, CA) or Jackson ImmunoResearch (West Grove, PA).
Reagents were from the following suppliers: PBS, HBSS, HAM F-10,
trypsin, culture media, and supplements (Invitrogen); Hibernate E
(BrainBits, Springfield, IL); DNase I, polyornithin, laminin, glial cell
line-derived neurotrophic factor (GDNF), taxol, and nocodazole
(Sigma), CNTF and BDNF (R & D Systems, Minneapolis, MN),
Vectashield–4,6-diamidino-2-phenylindole (Vector Laboratories,
Burlingame, CA); complete protease inhibitors andDormicum (Roche);
Hypnorm (Janssen, Beerse, Belgium); bisbenzimide and brefeldin A
(BFA) (Fluka, Saint Quentin Fallavier, France); and Fluoromount
(Southern Biotechnology, Birmingham, AL).
Mouse lines and genotyping. The pmnmice were maintained as/pmn
mice and Xt / pmn (“Xt/pmn”) mice (Brunialti et al., 1995) on a
mixed background (C57BL/6; 129/SvJ) using intercrosses (more than
F5). Lines of transgenic neuron-specific enolase (NSE):TBCEmice (Mar-
tin et al., 2002) were crossed with Xt/pmn mice and maintained as Xt/
pmnTBCEPA/ andXt/pmnTBCEPC/ stocks on the same genetic back-
ground. Thy1–yellow fluorescent protein (YFP) line 16 mice (Feng et al.,
2000) were used for the analysis of TBCE localization in peripheral
nerves. Mice were housed in animal facilities licensed by the French
Ministry of Agriculture (agreement A 75485), and experiments were
performed in strict compliance with European legislation.
Mouse genotyping was done as follows. The pmn and wild-type alleles
were detected using primers 5-GTCTTACTGCTCCCTACTTG (C45F)
and 5-GTGAAAACAGAAAGGGCAGAG (C45R) and 35 cycles of am-
plification (95°C, 40 s; 58°C, 40 s; 72°C, 40 s), followed by DNA purifi-
cation (QiaQuick; Qiagen, Hilden, Germany), 2 h incubation with the
restriction enzyme MnlI (New England Biolabs, Ipswich, MA), and gel
electrophoresis (3% Metaphor agarose; Tebu, Le Perray en Yvelines,
France). The NSE:TBCE transgene was detected by PCR using primers
5-CCAAGGAGATCGACTCTAGAG (NSE-7F), 5-AAGCGACTGT-
TCATATTC (TB-7R), 5-GATCATGACCGCCGTAGG (X1), and 5-
CATGAACTTGTCCCAGGCTT (X2), 35 cycles (92°C, 40 s; 58°C, 40 s;
72°C, 1 min) and 2% agarose gel electrophoresis.
Western blots and immunohistochemistry. Tissues were dissected from
deeply anesthetizedmice. Proximal and distal sciatic nerve segments of 4
mm length were dissected out, respectively, at the hip level and the knee
level. Mouse spinal cords and sciatic nerves were homogenized in lysis
buffer (150 mM NaCl, 50 mM Tris-HCl, 2 mM EDTA, 1% Triton X-100,
0.1% SDS, pH 7.4, and protease inhibitors). NSC34 cells were directly
lysed in Laemli’s buffer, subjected to SDS-PAGE, Western blotting, in-
cubated with antibodies, and revealed with the ECL plus system (GE
Healthcare, Little Chalfont, UK). Western blots were scanned and ana-
lyzed by densitometry (NIH ImageJ). For immunohistochemistry,
deeply anesthetized mice were perfused with 4% paraformaldehyde, and
spinal cords, sciatic nerves, and phrenic nerves were dissected, postfixed
overnight, and cryoprotected in 30% sucrose for 48 h. After tissue em-
bedding, 14 m transverse or 20 m frontal sections of the spinal cord
and 10mcross sections of nerveswere cut on a cryostat and collected on
glass slides. Sections were blocked, incubated overnight with primary
antibodies, washed, incubatedwith fluorochrome-conjugated secondary
antibodies, reacted with 0.1 g/ml bisbenzimide, and mounted in
Fluoromount.
Subcellular fractionation. Spinal cords or NSC34 cells were homoge-
nized in buffer (50 mM Tris-HCl, pH 7.5, 2 mM EGTA, 2 mM EDTA, 5%
sucrose, 0.1 mM DTT, and protease inhibitors) and centrifuged at 900
g for 10 min at 4°C to remove nuclei and cell debris. The postnuclear
supernatant was centrifuged for 1.5 h at 4°C and 60,000 rpm in a TLA-
100 rotor (Beckman Coulter, Fullerton, CA) to obtain cytosol and crude
membrane fractions. The membrane pellet was dissolved in homogeni-
zation buffer containing 0.5%Triton X-100 and incubated for 1 h on ice.
Equal volumes of subcellular fractions were subjected to SDS-PAGE and
processed as outlined above.
Retrograde labeling of motor neurons. Mice were anesthetized with
Hypnorm/Dormicum (fentanyl at 0.5 mg/ml, fluanisone at 2.5 mg/ml,
and midazolam at 1.25 mg/ml; 6 ml/kg body weight, s.c.). Under a ste-
reomicroscope, a ventral incision was made on the right side of the neck,
the cervical plexuswas isolated, and the phrenic nervewas identified. The
phrenic nerve was cut without opening the pleural cavity, and a piece of
hemostatic sponge (Spongostan; Ferrosan, Soeborg, Denmark) 1 1
1 mm in size was soaked in 10% Fluoro-ruby (Chemicon) in Ringer’s
solutionwith 2%DMSO, and applied to the proximal stump. Labeling by
dextran tracers is restricted to cut axons (Richmond et al., 1994), and care
was taken not to injure other branches of the cervical plexus or muscles
innervated by it. The wound was closed in two layers with 9-0 and 6-0
sutures.
Fluorescent, light, and electron microscopy. Confocal microscopy was
performed with upright or inverted LSM 510 microscopes (Zeiss,
Oberkochen, Germany) using 63, 40, or 10 objectives. For light
and electron microscopy, glutaraldehyde-fixed nerves and roots were
postfixed with osmic tetroxide and embedded in epoxy resin. For light
microscopy, cross sections 3 m thick were stained with
p-phenylenediamine, photographedwith a 40 oil immersion objective,
and printed to 1200 times. Thin cross sections for electron microscopy
were stained with uranyl acetate and lead citrate. To facilitate identifying
microtubules, the sections were tilted in the electron microscope
(CM100; Philips, Eindhoven, The Netherlands) by means of a goniom-
eter to obtain exact cross sections. The magnification of the microscope
was calibrated against a replica of a diffraction grating (2160 lines/mm).
With the aid of a digitizer tablet, all apparently intact myelinated axons
were counted on light micrographs of the phrenic nerves, axonal areas
were measured, and microtubules were counted on electron micro-
graphs printed to 60,000 times. The investigator (H.S.) was blinded
with respect to the genotype of the animals.
Expression plasmids and small interference RNAs. Expression vectors
for GFP–TBCE, hemagglutinin–TBCE, and FLAG–TBCE were gener-
ated by subcloning mouse wild-type TBCE cDNA using pCAGGS–GFP
(Jacquier et al., 2006) or pCMV–Tag1 vectors (Stratagene, La Jolla, CA)
as backbone. The GFP–-tubulin expression vector was generated by
subcloning a fragment from pAcGFP1–tubulin (Clontech) into
pCAGGS (Jacquier et al., 2006). Small interference RNAs (siRNAs)
against luciferase or TBCE were from Dharmacon (Chicago, IL). Tar-
geted regions of mouse TBCE (AY082332) were as follows: siTBCE 1,
nucleotides 118–137; siTBCE 2, nucleotides 242–262; siTBCE 3, nucle-
otides 792–812; siTBCE 4, nucleotides 1108–1126; and siTBCE pool,
equimolar mix of siTBCE 1–4.
Cell cultures and in vitro assays. Motor neurons were prepared from
embryonic day 12 spinal cords, electroporated with DNA plasmids
and/or siRNAs, and cultured in the presence of the neurotrophic factors
BDNF, CNTF, and GDNF (Raoul et al., 2002; Jacquier et al., 2006). For
immunocytochemistry, cells were fixed by adding an equal volume of 8%
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formaldehyde for 20 min at room temperature, blocked for 30 min in
PBS containing 5% goat serum, 1% BSA, and 0.5% Triton X-100, and
immunostained. NSC34 cells (Cashman et al., 1992) were cultured in
DMEM supplemented with 10% fetal calf serum and transfected with
DNA plasmids and lipofectamine (Invitrogen). To induce Golgi disas-
sembly, cells were treated with 10M brefeldin A for the indicated times,
and reassembly was induced by washout for 30 min in culture medium.
For quantification of GFP–-tubulin andDiscosoma red (DsRed) flu-
orescence, images were acquired in electroporated motor neurons cul-
tured for 2 or 3 d in vitro (DIV) from wild-type and pmn embryos or
transduced with siRNAs, respectively. Images from cell bodies or distal
axons were obtained by confocal microscopy in optical sections of 2.8
m using identical acquisition parameters in each experiment and ana-
lyzed by MetaMorph (Universal Imaging, Downingtown, PA). Ratios of
GFP–-tubulin to DsRed were calculated from mean fluorescent inten-
sities of each condition and experiment.
Microtubule growth assays were performed as described by Ahmad
and Baas (1995) with the following modifications. Primary motor neu-
rons were allowed to attach for 45 min. Microtubules were depolymer-
ized by adding 10Mnocodazole and incubated for 6 h at 37°C. Nocoda-
zole was washed out with warm culture medium, and neurons were
further incubated for 0, 1, or 30 min. Cultures were rinsed in PHEM (60
mM PIPES, 25 mM HEPES, 10 mM EGTA, 2 mM MgCl2, and 1% formal-
dehyde, pH 6.9) and extracted for 3 min in
PHEM containing 0.2% Triton X-100, and 20
M taxol, fixed, blocked, and immunostained
for III-tubulin and -tubulin to visualize mi-
crotubules and centrosomes, respectively. Im-
ages were obtained by confocal microscopy in
sections of 2.5 m optical thickness covering
the centrosome using identical acquisition pa-
rameters. Mean III-tubulin fluorescence and
the length of microtubules emanating from the
centrosome were measured using MetaMorph
and NIH ImageJ software, respectively.
Statistical analyses. Experiments were per-
formed in duplicate or triplicate and repeated at
least once. Data were analyzed with Excel (Mi-
crosoft, Seattle, WA); statistical testing and lin-
ear regression analysis were performed with
SigmaStat 3.1 (Systat, Evanston, IL).When data
showed a Gaussian distribution, they were ana-
lyzed with Student’s t test (two-tailed, un-
paired); otherwise the Mann–Whitney U test
was used.
Results
Retrograde progression of axonal
microtubule loss in pmnmice
Homozygous pmnmice develop first signs
ofmuscle atrophy and paresis at 2 weeks of
age and die by respiratory failure 4 to 5
weeks later (Schmalbruch et al., 1991).
Motor neuron degeneration in affected
mice starts at endplates and distal axons
and progresses retrogradely (Schmalbruch
et al., 1991). Proximalmotor axons in ven-
tral roots, however, show only modest de-
generation (Schmalbruch et al., 1991), and
spinal motor neuron cell bodies are pre-
served until end stage (Haase et al., 1997).
To assess the role of microtubules in the
axonal dying back process, we selected the
phrenic nerve that contains mainly motor
axons (Langford and Schmidt, 1983) and
analyzed it at a distal level, close to the di-
aphragm, and at an intermediate level cor-
responding to the thoracic inlet. We also
investigatedC4 ventral root nerves because they contain themost
proximal phrenic axons. As time points, we chose day 15 (disease
onset) and day 28 (advanced disease stage). Using electron mi-
croscopy, we determined microtubule number and axonal sur-
face in at least 10 entire cross-sectional axon profiles per nerve in
four wild-type and four pmn littermate mice (Fig. 1A,B).
In normal phrenic nerves, we counted a mean of 15.2  2.3
microtubules/m2 cross-sectional area of the distal axon (means
of mean  SD). In distal phrenic nerves of pmn mice, axonal
microtubule densities were reduced to 6.0  1.6 microtubules/
m2, corresponding to 39 10% of normal ( p 0.0001) (Fig.
1C,D, I). A similar reduction in axonal microtubule density
(44 9% of normal; p 0.0001) was found at the intermediate
level (Fig. 1I). Interestingly however, C4 ventral roots from pmn
mice displayed no significant reduction in axonal microtubule
density (89  5% of wild type) (Fig. 1E,F,I). Lumbar ventral
roots that supply the most severely affected territories in pmn
mice also showed normal axonal microtubule densities (97 
22% of wild type) (Fig. 1 I). These findings were further sup-
ported byWestern blot analysis of neuronal III-tubulin levels in
Figure 1. Axonal microtubules and tubulin levels in pmn mice. A, B, Electron micrographs showing entire cross sections
through distal phrenic nerves from 15-d-old early symptomatic pmnmice and wild-type (wt) littermate mice. C, D, High-power
electron micrographs from distal phrenic nerve axons at day 15. Microtubules (arrows) in pmn phrenic nerve axons are rarefied,
whereas intermediate filaments are preserved. E, F, High-power electron micrographs from C4 ventral roots at day 15. G, H,
High-power electronmicrographs from C4 ventral roots at day 28. Scale bars: A,B, 1m; C–H, 0.5m. I, Diagram showing that
axonal microtubule densities in pmn phrenic nervesmice are reduced by 61 and 56%, respectively, at the distal and intermediate
level compared with those in wild-type nerves (***p 0.0001, Student’s t test). No significant microtubule loss is observed in
cervical and lumbar ventral rootmotor axons of 15-d-old pmnmice. A total of 378 individual axon cross sectionswere analyzed. J,
Diagram showing reduction of microtubule densities in C4 ventral roots of 28-d-old pmnmice (***p 0.0001, Student’s t test).
K, Western blot analysis showing protein levels ofIII-tubulin and-actin in lysates from lumbar spinal cord and proximal and
distal sciatic nerves at day 15. Note the reduction ofIII-tubulin in distal sciatic nerves of pmnmice.
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distal and proximal sciatic nerves and
lumbar spinal cord of 15-d-old mice. In
pmnmice, the III-tubulin levels were sig-
nificantly reduced in distal sciatic nerves
but normal in proximal nerves and spinal
cord (Fig. 1K).
To analyze the temporal progression of
microtubule loss in pmn mice, we studied
C4 cervical ventral roots of 28-d-old pmn
mice (Fig. 1G,H). At this advanced disease
stage, microtubule densities were reduced
to 40  13% of normal (Fig. 1 J). Axonal
microtubule loss in pmn motor nerves
thus first manifests distally and then
progresses from distal to proximal, in par-
allel with the axonal dying back
neuronopathy.
Consequences of microtubule loss on
axon degeneration
We then investigated the requirement of
microtubules for motor axon mainte-
nance. To this purpose, we analyzed not
only pmn and wild-type mice but also two
lines of transgenic pmn mice comple-
mented with wild-type TBCE (Martin et
al., 2002), termed TBCEPA pmn and TB-
CEPC pmn. In TBCEPA pmn mice, disease
onset is retarded by 2–3weeks and survival
is prolonged; in TBCEPC pmn mice, dis-
ease is completely prevented. Using elec-
tronmicroscopy, we compared axonal pa-
thology andmicrotubule density in distal phrenic nerves of pmn,
wild-type and transgenic TBCE pmn mice (Fig. 2A–D). In
phrenic nerves of 15-d-old pmn mice, we observed numerous
axons with irregular contours (Fig. 2A) and a loss of 25% of
myelinated axons (195 25, mean SD) compared with wild-
type littermate mice (260  20, mean  SD) (Fig. 2C). In TB-
CEPA pmnmice, axon contour irregularities were present but less
prominent than in pmnmice (Fig. 2A), andmicrotubule loss was
observed in only one of four mice (Fig. 2B,D). In TBCEPC pmn
mice, axon contour irregularities were completely absent, and
axonal microtubule densities and numbers in phrenic nerves
were normal (Fig. 2A–C). Linear regression analysis revealed a
highly significant correlation between microtubule density and
axon numbers (r  0.939;   0.01; p  0.001) (Fig. 2D). Mi-
crotubule densities below 10/m2, corresponding to a microtu-
bule loss of 40% were associated with beginning axon loss.
Together, the clinical and EM data thus indicate a close correla-
tion between axonal microtubule density, motor axon mainte-
nance, and clinical disease course.
TBCE accumulates at the Golgi apparatus of motor neurons
To investigate the role of TBCE in the maintenance of axonal
microtubules, we studied its protein expression profile in the
peripheral nervous system. In immunoblots of adult spinal
cord extracts, our polyclonal antibody detected a single band
of 59 kDa, corresponding to recombinant TBCE (Fig. 3A). On
cervical spinal cord sections, TBCE was mainly expressed in
ventral horn motor neurons and in neurons of superficial dor-
sal horn layers (Fig. 3B). To verify that TBCE is expressed in
phrenic motor neurons in the cervical spinal cord, we used
retrograde rhodamine–dextran labeling. We found that all of
them expressed high levels of TBCE in their soma (Fig. 3C).
Surprisingly, however, TBCE was barely detectable in axons,
identified by neurofilament labeling (Fig. 3D) or genetic label-
ing (Fig. 3E) in Thy1–YFP line 16 mice (Feng et al., 2000). In
phrenic and sciatic nerves and also in cervical and lumbar
ventral roots, TBCE expression predominated in Schwann cell
bodies (Fig. 3D,E and supplemental Fig. 1, available at www.j-
neurosci.org as supplemental material).
In motor neurons, TBCE accumulated at discrete tubulove-
sicular structures surrounding the nucleus that were reminiscent
of the Golgi apparatus (Fig. 3F–I). Double immunolabeling and
confocal microscopic analysis confirmed a striking overlap (Fig.
3F,G) betweenTBCE and the two cis-GolgimarkersGM130 (Na-
kamura et al., 1995) and p115 (Sapperstein et al., 1995). The
TBCE-positive structures were often found juxtaposed to Vti1a-
stained trans-Golgi compartments (Fig. 3H) but clearly distinct
from Vti1b-stained post-Golgi compartments (Fig. 3I). TBCE
accumulation at the Golgi was also observed in Schwann cells, as
shown by TBCE and GM130 double immunolabeling (supple-
mental Fig. 1D,E, available at www.jneurosci.org as supplemen-
tal material). Golgi localization of TBCE was confirmed with a
second antibody against TBCE and specificity by antibody pre-
absorption on TBCE peptides or on recombinant TBCE proteins
(data not shown).
Previous TBCE overexpression studies in HeLa cells had de-
tected TBCEonly in the cytoplasm (Bhamidipati et al., 2000; Tian
et al., 2006). To test this, we overexpressed GFP- and FLAG-
tagged TBCE in the NSC34 motor neuron cell line (Cashman et
al., 1992). When expressed at a low level, tagged TBCE could be
clearly detected at Golgi membranes (supplemental Fig. 2A,
Figure 2. Requirements of microtubules for axonmaintenance. A, Electronmicrographs of distal phrenic nerves show irregu-
larly shapedmyelin sheaths andmyelin debris as signs of axonal atrophy and degeneration in 15-d-old pmnmice comparedwith
wild-type littermate mice. Signs of axonal degeneration are attenuated in transgenic TBCE PA pmn mice and virtually absent in
TBCE PC pmnmice.B, Diagram showing axonalmicrotubule densities in distal phrenic nerves of wild-type, pmn, TBCE PA pmn, and
TBCE PC pmn mice. C, Diagram showing number of myelinated axons in the distal phrenic nerves of mice with the indicated
genotypes. D, Histogram showing a close correlation between the number of myelinated fibers ( y-axis) and axonal microtubule
density (x-axis) in individual phrenic nerves ( p 0.001;  0.01; r 0.939). A microtubule loss of40% (microtubule
density below 10/m2) was associated with beginning axon loss. Genotypes are as follows:f, pmn;, wild type;Œ, TBCE PA
pmn;‚, TBCE PA wild type;F, TBCE PC pmn;E, TBCE PC wild type. Scale bar, 10m.
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available at www.jneurosci.org as supplemental material). After
high-level expression, however, tagged TBCE was found exclu-
sively in the cytoplasm. This discrepancy is probably due to the
fact that high-level TBCE overexpression disrupts the cellular
microtubule network that is required for maintenance of the
Golgi apparatus (supplemental Fig. 2A–C, available at www.
jneurosci.org as supplemental material).
Golgi proteins can bemembrane bound, like the Golgi matrix
protein GM130 (Nakamura et al., 1995), or peripheral
membrane-associated, like the vesicle-tethering protein p115,
which shuttles betweenmembrane and cytosolic pools (Brandon
et al., 2006). To distinguish between these possibilities for TBCE,
we prepared subcellular fractions from spinal cord. TBCE was
present in both crude membrane and cytosolic fractions, in a
ratio similar to p115 (Fig. 3J). GM130 was found exclusively in
the membrane fraction, as expected (Fig. 3J). Collectively, our
immunohistochemical and biochemical data thus identify TBCE
as the first tubulin-specific chaperone that accumulates at the
Golgi apparatus.
TBCE is destabilized at the Golgi
apparatus in pmnmice and is restored
by transgenic TBCE complementation
To explore the molecular causes of mi-
crotubule loss in pmn mice, we analyzed
whether the protein levels or subcellular
localization of TBCE were modified in
pmn motor neurons in vivo. Our previ-
ous in vitro studies had indicated that the
pmn mutation alters the conformation
and reduces the half-life of the TBCE
protein (Martin et al., 2002). Western
blot analyses now showed that TBCE
protein levels in pmn spinal cords were
drastically lower than in wild-type spinal
cords at both disease onset (Fig. 4A) and
end stage (Fig. 4B). Immunofluores-
cence analyses confirmed that TBCE ex-
pression at the Golgi apparatus was re-
duced in cervical and lumbar pmnmotor
neurons at postnatal day 15 (P15) (Fig.
4C–E) and P35 (data not shown). Simi-
lar observations were made in Schwann
cells in the sciatic nerve (supplemental
Fig. 1B–E, available at www.jneurosci.
org as supplemental material). In con-
clusion, the pmn mutation destabilizes
TBCE and reduces its steady-state levels
at the Golgi apparatus in vivo.
To determine the levels of TBCE pro-
tein required for motor axon mainte-
nance, we analyzed the two lines of
transgenic TBCE pmn mice. In these
mice, wild-type TBCE is expressed under
control of the neuron-specific NSE pro-
moter (Forss-Petter et al., 1990). West-
ern blot analyses showed that spinal cord
levels of TBCE protein were intermedi-
ate in TBCEPA pmn mice and supranor-
mal in TBCEPC pmn mice compared
with pmn and wild-type mice (Fig.
4A,B). Immunostainings of cervical and
lumbar spinal cord motor neurons
showed that TBCE expression at the
Golgi apparatus was partially restored in TBCEPA pmn mice
and normal in TBCEPC pmn mice (Fig. 4D,E). Together, the
biochemical, electron microscopic, and clinical data thus
demonstrate that TBCE protein levels in spinal motor neurons
determine the histopathological and phenotypic severity of
progressive motor neuronopathy.
Effects of TBCE depletion in motor neuron cultures
Microtubules are made of /-tubulin dimers that are generated
in a complex biological process requiring the sequential action of
prefoldin, CCT (cytosolic chaperonin complex), and five
tubulin-specific chaperones. During this process, TBCE assists in
the folding of -tubulin and the formation of /-tubulin het-
erodimers (Tian et al., 1996, 1997). To investigate the function of
TBCE in motor neurons, we performed RNA interference-
mediated TBCE depletion experiments in NSC34 cells. Western
blot analysis showed that endogenous TBCE was efficiently de-
pleted by siRNAs (Fig. 5A). TBCE depletion had no effect on total
levels of - or III-tubulin (Fig. 5A). TBCE-depleted cells, how-
Figure 3. TBCE accumulation at the Golgi apparatus of spinal motor neurons. A, Western blot analysis shows that a polyclonal
antibody directed against murine TBCE detects a band of59 kDa in adult spinal cord protein extracts and in COS cells overex-
pressing TBCE. B, Immunolabeling for TBCE in an adult cervical spinal cord cross section. C, TBCE immunostaining in retrogradely
labeled phrenic motor neurons on a frontal section of adult cervical spinal cord. D, Immunolabeling for TBCE and neurofilament
medium chain (NF) in a ventral root shows that TBCE is barely detectable in axons. E, Triple labeling for TBCE (in red), S-100 (in
blue), and theaxon (ingreen) in the sciatic nerveof a Thy1–YFP line16mouse showsTBCEexpression in the cell bodyof a Schwann
cell. F, G, Immunolabeling for TBCE and the cis-Golgi markers GM130 (F ) or p115 (G) demonstrates that TBCE decorates cis-Golgi
membranes inmotor neurons of adult spinal cord.H, I, Immunolabeling for TBCE andVti1a (H ), a trans-Golgimarker, or Vti1b (I ),
a marker of post-Golgi compartments. Insets showmagnified areas depicted by arrows. Scale bars: B–D, 100m; E, 5m; F–I,
20m. J, Western blot analysis showing distribution of TBCE, p115, and GM130 in postnuclear, cytosolic, and crude membrane
fractions of spinal cord.
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ever, contained more soluble and less pre-
cipitable, microtubule-incorporated,
-tubulin than control cells (Fig. 5B,C),
suggesting that some -tubulin was not
correctly folded and polymerization
incompetent.
In neurons, tubulins aremainly synthe-
sized in the cell body (Eng et al., 1999), and
most of them are rapidly routed into the
axon (Campenot et al., 1996). Our in vivo
observations in pmnmice showed thatmi-
crotubule loss starts in the distal axon and
progresses retrogradely. We therefore
wondered whether TBCE is required for
axonal tubulin routing. To address this
question, we used embryonic motor neu-
rons in primary culture. To monitor their
axonal tubulin routing, we electroporated
them with a GFP–-tubulin expression
vector along with a DsRed vector and
siRNAs. In si-luciferase-transduced con-
trol motor neurons, newly synthesized
GFP–-tubulin and DsRed were evenly
distributed in cell bodies and axons (Fig.
5D). In TBCE-depleted motor neurons,
however, the amount of GFP–-tubulin
was reduced in distal axons (Fig. 5D). We
therefore compared the fluorescence ra-
tios of GFP–-tubulin with DsRed in mo-
tor neuron cell bodies and axons by con-
focal microscopy and quantitative image
analysis (Fig. 5D–G). In cell bodies of
TBCE-depleted cells, the mean GFP–-
tubulin/III-tubulin fluorescence ratio
was reduced to 74.3 1.7% of the ratio in
control cells (mean  SD; p  0.01) (Fig.
5G). In distal axons of TBCE-depleted
cells, this ratio was reduced to 41.9  1.6% of the control value
(mean  SD; p  0.01) (Fig. 5G), which is significantly lower
than the reduction in the cell bodies. These results indicate that
TBCE in motor neurons is not only required for proper tubulin
folding but also for its axonal routing.
Microtubule polymerization and axonal routing in pmn
motor neurons
To test the consequences of the pmn mutation on microtubule
polymerization, we examined pmn and wild-typemotor neurons
in culture. Motor neurons were purified from individual em-
bryos, seeded, and incubated for 6 h with 10 M nocodazole to
depolymerize microtubules (Ahmad and Baas, 1995). In wild-
type motor neurons, microtubules began to emanate from the
centrosome as early as 1 min after nocodazole washout and
formed extended microtubule asters at 30 min (Fig. 6A). In pmn
motor neurons,microtubule polymerizationwas initially normal
but severely affected at 30 min (Fig. 6B). At this time, the immu-
noreactivity of microtubule-incorporated III-tubulin was re-
duced to 43.9 8.1% of wild type (mean SD; p 0.0001) (Fig.
6C), and microtubules were significantly shorter than in wild-
typemotor neurons (Fig. 6D). These results indicate that the pmn
mutation in TBCE impairs microtubule polymerization.
We next analyzed axonal tubulin routing in pmnmotor neu-
rons. Motor neurons were electroporated with GFP–-tubulin
and DsRed plasmids and cultured for 2 DIV. In cell bodies, the
mean GFP–-tubulin/III-tubulin fluorescence ratios were not
significantly different between pmn andwild-typemotor neurons
(Fig. 6F). In distal axons of pmn motor neurons, however, the
meanGFP–-tubulin/DsRed ratiowas reduced to 54.2 9.6%of
wild type ( p 0.05) (Fig. 6E,F). The reduction of tubulin levels
in distal axons of pmn motor neurons indicates that the pmn
mutation in TBCE compromises axonal tubulin routing.
The Golgi apparatus controls axonal tubulin routing in
motor neurons
To test whether the Golgi apparatus is involved in axonal tubulin
routing, we pharmacologically disrupted this organelle with BFA.
BFA inhibits activation of ADP-ribosylation factors (Donaldson
et al., 1992), which causesGolgi disassembly and redistribution of
its components into the endoplasmic reticulum (Lippincott-
Schwartz et al., 1990), the cytosol (Klausner et al., 1992), or into
so-calledGolgi remnants (Seemann et al., 2000). Inmock-treated
NSC34motor neurons (Fig. 7A), we foundTBCE to be associated
with GM130-stained cis-Golgi membranes, as in vivo. In BFA-
treatedmotor neurons, GM130 localized to dispersed Golgi rem-
nants, as expected, but TBCE was redistributed into the cytosol
(Fig. 7A). The BFA-induced cytosolic TBCE redistribution was
reversible on BFA washout (Fig. 7A) and not accompanied by a
modification in cellular TBCE levels (Fig. 7B). Immunoblot anal-
yses further confirmed that BFA had no significant effect on the
Figure4. Loss of TBCE expression at the Golgi apparatus of pmnmice and its restoration by transgenic TBCE complementation.
A, B, Western blot analysis showing protein levels of TBCE and neurofilament-M (NF-M) in spinal cord lysates of wild-type (wt),
pmn, TBCE PA pmn, and TBCE PC pmnmice at P15 (A) and P35 (B). C, Immunolabeling showing reduced TBCE expression in spinal
cord motor neurons of pmn mice at P15. D, E, Immunolabeling showing TBCE protein expression in cervical (D) and lumbar (E)
spinal cord motor neurons of wild type, pmn, TBCE PA pmn, and TBCE PC pmnmice at P15. Scale bars: C, 100m; D, 10m.
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total cellular amounts of GM130, -tubulin, or -tubulin (Fig.
7B) under these experimental conditions.
To test the effects of Golgi disruption on axonal tubulin rout-
ing, we electroporated motor neurons with GFP–-tubulin or
GFP plasmids, treated them with BFA or mock (Fig. 7C), and
counterstained them for III-tubulin. BFA had no obvious effect
on the levels or intracellular distribution ofGFP (data not shown)
or endogenous III-tubulin (Fig. 7C). BFA, however, modified
the intracellular distribution of GFP–-tubulin. In BFA-treated
motor neurons, GFP–-tubulin was predominantly found in cell
bodies and strikingly diminished in axons (Fig. 7C,D). Quantita-
tive confocal analyses in distal axons of BFA-treated motor neu-
rons confirmed that the ratio of GFP–-tubulin fluorescence to
III-tubulin fluorescence was reduced to 33.3  4.8% (mean 
SD) of the ratio in mock-treated motoneurons ( p  0.05 as
analyzed per Student’s t test; n  30 cells per condition). BFA-
induced Golgi disruption and TBCE depletion, albeit differing in
their molecular mode of action, thus have very similar effects on
axonal tubulin routing. These data indicate that axonal tubulin
routing inmotor neurons is controlled at theGolgi apparatus and
implicate TBCE in this process.
Discussion
Subcellular origin of axonal degeneration
Axonal degeneration, whether of traumatic, toxic, or genetic or-
igin, often manifests as axonal dying back: distal axons are af-
fected first, and degeneration apparently progresses fromdistal to
proximal (Cavanagh, 1964; Coleman, 2005). The subcellular or-
igin of such dying back processes remains debated (Conforti et
al., 2007). “Centroneuronal” hypotheses have attributed the ax-
onal dying back to dysfunction of the neu-
ronal perikaryon and progressive with-
drawal of metabolic support to the axon
(Cavanagh, 1964) or to defects in the prox-
imal axonal cytoskeleton and blockade of
anterograde axonal transport (Griffin and
Watson, 1988). “Axonal” hypotheses pos-
tulated that the degenerative process is
triggered in the axon itself: Vincristine, a
chemotherapeutic agent used in human
cancer therapy, causes a peripheral neu-
ropathy with prominent distal axonal de-
generation (Bradley et al., 1970). The ax-
onal dying back process can be mimicked
in neuronal cultures (Ravula et al., 2007)
inwhich topic application of Vincristine at
clinically relevant concentrations injures
the axon but not the neuronal soma (Silva
et al., 2006). Several genetic studies have
also linked impaired retrograde axonal
transport to motor neuron degeneration.
Mutation or disruption of the motor pro-
tein complex dynein/dynactin for example
cause progressive motor neuron degener-
ation inmice (LaMonte et al., 2002;Hafez-
parast et al., 2003) and humans (Puls et al.,
2003).
Retrograde microtubule loss in
pmnmice
We here investigated how a missense mu-
tation in TBCE causes axonal dying back
in pmn mice. We show that in normal
mice, TBCE is expressed in motor neuron
cell bodies in which it accumulates at the cis-Golgi apparatus. In
early symptomatic pmnmice, TBCE is destabilized and lost from
this organelle. Microtubules are first lost in distal motor axons
and only at end stage in proximal motor axons. This retrograde
microtubule loss parallels the axonal dying back: at disease onset,
the extent of microtubule loss in distal phrenic nerves correlates
with the severity of axonal degeneration and the axonal loss. At
end stage of disease, microtubules (this study) and axonal diam-
eters (Schmalbruch et al., 1991) are also reduced in ventral roots.
We further show that neuron-specific TBCE complementation
restores TBCE levels in spinal motor neurons of pmn mice and
inhibits microtubule loss, axonal degeneration, and clinical dis-
ease in a dose-dependent manner. These data indicate that desta-
bilization of TBCE inmotor neurons is responsible for the axonal
dying back process in pmnmice.
How can a defective tubulin chaperone cause axonal
dying back?
Using cultured pmnmotor neurons, we show that the pmnmu-
tation compromises the routing of newly synthesized tubulin
from the cell body to the distal axon and impedes the incorpora-
tion of tubulin into growing microtubules. In vivo analyses of
early symptomatic pmnmice further demonstrate that neuronal
III-tubulin levels are reduced in distal sciatic nerves but normal
in proximal nerves and corresponding lumbar spinal cord seg-
ments. Hoffman et al. (1992) reported that tubulins are antero-
gradely transported and continuously deposited into stationary
axonal microtubules, which are stabilized when axons mature
(Watson et al., 1990). Zenker and Hohberg (1973) emphasized
Figure 5. Role of TBCE in tubulin formation and axonal routing. A, TBCE depletion in NSC34 cells. Western blots showing total
levels of TBCE,- andIII-tubulin, and-actin in cells 3 d after transfection of si-luciferase, si-TBCE 1, or si-TBCE pool.B,Western
blot showing increased amounts of soluble -tubulin (S) and reduced amounts of precipitable -tubulin (P) in subcellular
fractions of TBCE-depleted NSC34 cells compared with control cells. T, Total tubulin in postnuclear supernatant. C, Diagram
showing the increased ratio of soluble to precipitable-tubulin in TBCE-depletedNSC34 cells. Valueswere determined fromblots
of five independent experiments. siTBCE, 39 12; si-luciferase, 13 11 (means SD). *p 0.005, Student’s t test. D–F,
Images of primary motor neurons at 3 DIV after electroporation with GFP–-tubulin and DsRed expression vectors and siRNAs.
Shown are low-powermagnifications of neurons (D) and high-powermagnifications of cell bodies (E) and distal axons (F ). Note
diminished GFP–-tubulin fluorescence in the distal axons of TBCE-depleted motor neurons. G, Diagram showing the ratio of
GFP–-tubulin to DsRed fluorescence in cell bodies and distal axons of electroporatedmotor neurons. After TBCE depletion, this
ratio is significantly lower in distal axons than in cell bodies. Scale bars:D, 50m; E, F, 10m. Statistical significance: *p 0.01,
Student’s t test. Data represent means of means SD from three independent experiments (n 75 neurons per condition).
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that the proximal motor axon has a much
smaller cross-sectional area and contains
many fewer microtubules than all of its
distal branches taken together. They found
that the combined cross sections through
all terminal axons of a typical A--motor
neuron contain 11 times asmanymicrotu-
bule profiles as the stem axon. These data
suggest that defective axonal tubulin rout-
ing leads to reduced tubulin supply to dis-
tal axons and thereby causes microtubule
rarefaction. Motor neurons might be par-
ticularly vulnerable to defective tubulin
routing because of their extremely long
axons and their extended axonal
arborizations.
What is the role of the Golgi apparatus
in axonal tubulin routing?
Studies in cultured neurons have shown
that axonal tubulins are mainly synthe-
sized in the cell soma (Eng et al., 1999) and
transported into the distal axon within 2 d
after synthesis (Campenot et al., 1996).
Metabolic labeling experiments in com-
partmentalized cultures had provided
evidence that this process depends on
the Golgi apparatus (Campenot et al.,
2003). Using immunohistochemical and
biochemical experiments, we clearly iden-
tify TBCE as a peripheral membrane-
associated protein of cis-Golgi membranes
in vivo. In vitrodata in culturedNSC34 and
primary motor neurons further confirm
the accumulation of tagged and endoge-
nous TBCE at this organelle. Functional
TBCE depletion assays indicate that TBCE
is required for axonal routing of tubulins,
and BFA-mediated Golgi disruption ex-
periments indicate that this process de-
pends on an intact Golgi apparatus. TBCE
is thus related to a growing number of
Golgi proteins that control microtubule
formation or dynamics, such as GMAP-
210 (Golgi microtubule-associated pro-
tein of 210 kDa) (Infante et al., 1999; Rios
et al., 2004), AKAP350 (A kinase anchor
protein 350) (Larocca et al., 2006), and
CLASPs 1/2 (cytoplasmic linker associated
proteins 1/2) (Mimori-Kiyosue et al.,
2005).
Are defects in tubulin chaperones also
implicated in other forms of
axonal degeneration?
Human TBCE deletions have been found
in children with HRD (hypoparathyroid-
ism, growth retardation, dysmorphism)
syndrome (Parvari et al., 2002) that even-
tually develop motor neuron disease
symptoms when becoming elder (Parvari
et al., 2007). The TBCE-related tubulin
chaperone TBCB has been reported to be
Figure 6. Microtubule polymerization and axonal tubulin routing in cultured pmn motor neurons. A, B, Images showing
microtubule regrowth in wild-type (wt) and pmnmotor neurons at 0, 1, and 30min after nocodazole washout. Microtubules are
labeled forIII-tubulin and centrosomes for-tubulin. Note complete microtubule depolymerization at the 0 min time point. C,
Time course of microtubule regrowth after nocodazole washout. At 30min, pmnmotor neurons display a significant reduction in
III-tubulin immunofluorescence levels comparedwith wild-typemotor neurons ( p 0.0001, Mann–Whitney U test, arbitrary
units). Each data point represents 120 cells from three independent experiments.D, Microtubule length distribution 30min after
nocodazolewashout.pmn, 3.21.5m;wild type, 4.11.6m(meansSD) ( p0.0001,Mann–WhitneyU test;n120
per genotype). E, Images of distal axons fromwild-type and pmnprimarymotor neurons electroporatedwith GFP–-tubulin and
DsRed expression vectors and analyzed at 2DIV by quantitative image analysis.F, Diagramshowing the ratio of GFP–-tubulin to
DsRed fluorescence in cell bodies and distal axons of wild-type and pmnmotor neurons. In distal axons, this ratio is significantly
lower in pmn than in wild-type motor neurons (*p 0.05, t test). Data represent means SD from two independent experi-
ments (60 cells per genotype). Scale bars: A, 2m; E, 10m.
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dysregulated in gigaxonin knock-out mice, a model of human
giant axonal neuropathy (Wang et al., 2005). Gigaxonin binds
TBCB, promotes its poly-ubiquitination and thereby targets it to
the proteasome for degradation. The absence of gigaxonin leads
to an accumulation of TBCB and a loss of microtubules in neu-
rons (Wang et al., 2005). Interestingly, gigaxonin, like TBCE,
localizes at the Golgi apparatus (Cullen et al., 2004). Wobbler
mice, a model of progressive motor neuron degeneration, are
mutated in VPS54 (vacuolar protein sorting 54), a protein of the
Golgi-associated retrograde complex (Schmitt-John et al., 2005).
In these mice, defective axonal transport (Mitsumoto and Gam-
betti, 1986) and progressive axonal degeneration (Mitsumoto
and Bradley, 1982) are associated with downregulation of the
tubulin chaperone TBCA and of 3-tubulin (Perrin et al., 2006).
The role of tubulin chaperones and their interactors at the Golgi
apparatus thus warrants additional investigations.
Therapeutic implications
In the past, pmnmice have been instrumental in developing new
axonoprotective strategies. Crossing of pmnmicewithWldSmice
reduced axonal degeneration and extended the lifespan of pmn
mice (Ferri et al., 2003). The mechanisms remained enigmatic
because WldS is a nuclear protein and undetectable in axons.
Recently, Simonin et al. (2007) reported an upregulation of
kinesin-1 in pmn WldS motor neurons. Together, these data,
the known role of kinesins in axonal tubulin transport (Terada et
al., 2000; Kimura et al., 2005), and our findings raise the possi-
bility that WldS protects pmnmotor neurons by recovering their
deficit in axonal tubulin supply. Various studies have also shown
that gene therapy with neurotrophic factors can provide substan-
tial therapeutic benefit to pmnmice (Sendtner et al., 1992; Sagot
et al., 1995a; Haase et al., 1997; Bordet et al., 1999). It has been
shown that neurotrophic factors can be internalized into signal-
ing endosomes and retrogradely transported toward the Golgi
apparatus (Howe and Mobley, 2005). This suggests that neuro-
trophic factors exert some of their therapeutic effects by modu-
lating Golgi function and axonal tubulin routing.
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